Along with the rest of the industry, Modern Healthcare is eager to hear what President Donald Trump has to say about drug prices. But that's not all we are watching this week.
Home health agencies are treating sicker patients, yet they lack some of the basic tools needed to prevent infections.
New research suggests policymakers need to directly address prices rather than focusing on value-based care.
The American Medical Association and the American Society of Addiction Medicine have developed a new way to reimburse physicians who treat patients for opioid use disorder.
The parent of Blue Cross & Blue Shield of Illinois, the state's largest insurer, made more than a billion dollars last year, rebounding after three years of Affordable Care Act-related duress.
Tennessee Gov. Bill Haslam has said previously that he would sign the bill to impose work requirements on some people receiving Medicaid benefits.
Community Health Systems has signed a definitive agreement to sell Munroe Regional Medical Center in Ocala, Fla., to Adventist Health System Sunbelt Healthcare Corp.
The FDA is encouraging drugmakers to conduct fewer clinical trials on certain proposed medication-assisted therapies for opioid use disorder, saying a streamlined approach will help patients access treatment quicker.
McKay-Dee Hospital in April 2017 opened a center specifically for patients experiencing a mental health crisis.
Several medical associations blasted a value-based payment system created by MACRA for potentially causing harm to patients and sparking millions of dollars in financial penalties for providers.
Because of the horrendous public health consequences of rampant gun violence, it's incumbent on every healthcare leader to join the #NeverAgain movement.